A share price of Atyr Pharma Inc [ATYR] is currently trading at $4.32, down -2.48%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ATYR shares have gain 20.33% over the last week, with a monthly amount glided 23.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Atyr Pharma Inc [NASDAQ: ATYR] stock has seen the most recent analyst activity on February 18, 2025, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $16. On October 04, 2024, Wells Fargo initiated with a Overweight rating and assigned a price target of $17 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $9 on September 05, 2024. Oppenheimer downgraded its rating to a Perform. RBC Capital Mkts started tracking with a Outperform rating for this stock on October 12, 2021, and assigned it a price target of $22. In a note dated September 21, 2021, Piper Sandler initiated an Overweight rating and provided a target price of $19 on this stock.
Atyr Pharma Inc experienced fluctuations in its stock price throughout the past year between $1.42 and $4.57. Atyr Pharma Inc [NASDAQ: ATYR] shares were valued at $4.32 at the most recent close of the market.
Analyzing the ATYR fundamentals
Trailing Twelve Months sales for Atyr Pharma Inc [NASDAQ:ATYR] were 0.23M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at -5.64% with Operating Profit Margin at -289.59%, Pretax Profit Margin comes in at -271.55%, and Net Profit Margin reading is -271.56%. To continue investigating profitability, this company’s Return on Assets is posted at -0.7, Equity is -0.79 and Total Capital is -0.88. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.20 points at the first support level, and at 4.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.55, and for the 2nd resistance point, it is at 4.78.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Atyr Pharma Inc [NASDAQ:ATYR] is 5.41. Further, the Quick Ratio stands at 5.41, while the Cash Ratio is 0.81. Considering the valuation of this stock, the price to sales ratio is 1576.65, the price to book ratio is 5.01.
Transactions by insiders
Recent insider trading involved Broadfoot Jill Marie, Chief Financial Officer, that happened on Feb 04 ’25 when 1254.0 shares were sold. General Counsel, DENYES NANCY completed a deal on Feb 04 ’25 to sell 899.0 shares. Meanwhile, Director SCHIMMEL PAUL bought 52300.0 shares on Jul 24 ’24.
